This study aimed to assess the molecular basis of the resistance to carbapenems in clinical isolates of Pseudomonas aeruginosa recovered from a tertiary-level health facility in San José , Costa Rica. A total of 198 non-duplicated isolates were evaluated for their susceptibility to b-lactams, aminoglycosides and fluoroquinolones. The production of metallo-b-lactamases (MBLs), the presence of MBL encoding genes (bla IMP , bla VIM and bla GIM-1 ) and the occurrence of these genes within class 1 integrons were investigated. In addition, an ERIC2 PCR fingerprinting method was used to elucidate the distribution of the detected MBL genes within the strain collection. Of the 198 isolates tested, 125 (63.1 %) were categorized as carbapenem-resistant. The majority (88.8 %) of the carbapemen-resistant isolates also showed resistance to ceftazidime, cefepime, aztreonam, ticarcillin/clavulanic acid, amikacin, gentamicin, tobramycin, ciprofloxacin and gatifloxacin. Among the carbapenem-resistant isolates, 102 (81.6 %) showed MBL activity. Strikingly, both bla IMP and bla VIM genes were simultaneously detected in most (94.1 %) of the 102 MBL producers. Five carbapenem-resistant MBL producers were positive only for bla IMP genes. Almost 70 % of the isolates examined harboured the intI1 gene, accompanied by the sul1 and qacED1 genes in 136 (99 %) and 122 (89 %) isolates, respectively. The majority (94.4 %) of the carbapenem-resistant isolates carried the intI1 gene, in contrast to 26 % of the carbapenem-susceptible isolates. Ninety-three out of 96 (96.9 %) isolates carrying both bla IMP and bla VIM genes also harboured the intI1, sul1 and qacED1 genes. Gene cassettes from carbapenem-susceptible and MBL-negative carbapenem-resistant isolates encoded aminoglycoside-resistance enzymes (aadA2, aadA4 and aadA6) as well as orfD and qacF genes. RAPD analysis distributed 126 of the isolates in 29 clusters. Eighty of the 90 bla IMP + bla VIM + isolates were sorted into 16 different clusters, suggesting that the bla IMP and bla VIM genes detected were located within a genetic element capable of lateral transfer. Carbapenem-resistant MBL-positive isolates were recovered from almost all hospital wards and were over-represented in samples obtained from the surgical emergency and intensive care therapy units. Remarkably, three carbapenem-resistant isolates, exhibiting MBL activity and carrying both bla IMP and bla VIM genes, were recovered from outpatients. Sequence analysis of both bla genes in various isolates revealed that they correspond to the alleles bla IMP-18 and bla VIM-2 . To our knowledge, this is the first report of the combination of two metallo-b-lactamases encoded by the bla IMP-18 and bla VIM-2 genes in P. aeruginosa.
INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative bacterium with extraordinary physiological and metabolic versatility. This organism has a wide distribution in nature and colonizes various ecological niches, such as aquatic and terrestrial plants and animals, including humans. Moreover, it tolerates a variety of physical conditions, and is able to persist in both community and hospital settings (Klockgether et al., 2011; Silby et al., 2011) . Despite its wide distribution in nature and its potential to cause community-acquired infections, serious infections with P. aeruginosa are predominantly hospital acquired. P. aeruginosa causes a wide variety of infections including respiratory, urinary tract, skin and soft tissue infections, as well as a variety of systemic infections in patients with severe burns, cancer, cystic fibrosis, AIDS and other conditions leading to a state of immunosuppression (Foca, 2002; Garau & Gomez, 2003; Maschmeyer & Braveny, 2000; Rajan & Saiman, 2002) . Although this bacterium is a relatively rare component of the normal human microbiota, the colonization rate of patients by P. aeruginosa during hospitalization can exceed 50 % (Morrison & Wenzel, 1984) .
The treatment and control of P. aeruginosa infections acquired both in the community and in hospitals is a serious therapeutic challenge, for which the selection of appropriate antibiotics for initiation of therapy is essential. The spread of this bacterium is difficult to control with disinfectants and antibiotics due to the many intrinsic and acquired mechanisms of resistance found commonly in P. aeruginosa isolates (Breidenstein et al., 2011; Lambert, 2002; Lister et al., 2009) . The global emergence of P. aeruginosa resistance to multiple antibiotics, including blactams, aminoglycosides and fluoroquinolones, currently represents an extraordinary threat to public health (Andrade et al., 2003; Lister et al., 2009; Master et al., 2011; Talbot et al., 2006) . Carbapenem resistance in P. aeruginosa is particularly worrisome because this class of b-lactams represents the last therapeutic resource for the control of bacterial infections. Although porins and efflux pumps may contribute to the phenotype of carbapenem resistance in P. aeruginosa, the most relevant resistance mechanism is the production of carbapenem-hydrolysing enzymes. The first class B MBLs in P. aeruginosa were identified in 1991 in Japan (Watanabe et al., 1991) . Since that initial report, MBLs have been reported for P. aeruginosa isolates from nearly all regions of the world, with six major families identified so far (IMP, VIM, SPM, GIM, AIM, and FIM) (Cornaglia et al., 2011; Pollini et al., 2013) . Serine-blactamases with carbapenemase activity have also been reported in P. aeruginosa, including the class-A enzymes KPC (Villegas et al., 2007; Wolter et al., 2009 ) and GES-18 (Bebrone et al., 2013) and class-D enzymes OXA-40 (Sevillano et al., 2009) and OXA-198 (El Garch et al., 2011) .
Isolation of carbapenem-resistant P. aeruginosa is relatively common in some major hospitals in San José, Costa Rica and represents an important threat to the local health-care system. The aim of this study was to determine the susceptibility of a collection of P. aeruginosa isolates recovered at one tertiary-level hospital in Costa Rica to b-lactams, aminoglycosides and fluoroquinolones, to clarify whether these isolates carry IMP, VIM, or GIM-1 MBLs, and to evaluate the association of these genes with class 1 integrons.
METHODS
Bacterial strains. A total of 198 independent clinical isolates were randomly selected among 708 P. aeruginosa isolates obtained between November 2004 and October 2005 at the Hospital Mexico (San José, Costa Rica), a tertiary-level health facility with 519 beds. These isolates were recovered from patients hospitalized in the intensive care unit (n546) or the general wards (n5140), or from outpatients (n512). The selected isolates were recovered from a variety of clinical specimens including respiratory tract (n562), urine (n559), secretion (n548) and other (n529) specimens. This latter category comprises a diversity of clinical samples with low numbers. P. aeruginosa ATCC 27853, Escherichia coli ATCC 25922, and E. coli ATCC 35218 were used as susceptible controls. P. aeruginosa A5386 (bla IMP-1 ), P. aeruginosa A3486 (bla IMP-18 ), P. aeruginosa 75-3636C (bla VIM-1 ), P. aeruginosa 81-11963A (bla VIM-2 ) and P. aeruginosa 73-5671 (bla GIM-1 ), kindly provided by Dr Ana C. Gales (Laborató rio Especial de Microbiologia Clínica, Brazil), were used as positive controls for PCR amplification of metallo-b-lactamase genes. E. coli DH5a (F 2 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG
were used as host strains to propagate recombinant plasmids.
In vitro susceptibility tests. The isolates were identified at the species level using GNI cards (bioMériux Vitek). This automated system and AST-GN cards were also employed to determine their susceptibility to ceftazidime, cefepime, aztreonam, imipenem, meropenem, ticarcillin/clavulanic acid, piperacillin/tazobactam, amikacin, gentamicin, tobramycin, ciprofloxacin and gatifloxacin. Some of the P. aeruginosa isolates showing intermediate susceptibility were considered resistant in the statistical analysis. Metallo-b-lactamases were phenotypically detected using E-test MBL strips following the manufacturer9s instructions (AB Biodisk).
Detection of genes encoding metallo-b-lactamases by multiplex PCR. DNA isolation was performed as described previously (Speijer et al., 1999) . Multiplex PCR analysis for detection of bla IMP , bla VIM and bla GIM-1 was performed as described by Mendes et al. (2007) . Amplification products were separated by electrophoresis on 1.5 % (w/v) agarose gels and visualized using ethidium bromide. A Mass Ruler DNA Ladder (Fermentas) was used as a size marker.
Detection and nucleotide sequence analysis of class 1 integrons. All isolates were initially screened for the integrase gene intl1 with primers IntA and IntB. Thereafter, primers sul1 and sul1.rev, and orf4 and sul1.rev were used to detect sul1 and qacDE1 genes contained in 39-conserved segments (Lévesque et al., 1995; Rosser & Young, 1999) . Primers 59CS and 39CS were used to amplify gene cassettes while primers Int2F and 39CS were used to amplify variable segments comprising a fragment of the integrase gene and the inserted cassettes (Lévesque et al., 1995) . All amplification reactions were performed as previously described (Lévesque et al., 1995; Rosser & Young, 1999) and PCR products were visualized by gel electrophoresis as indicated above.
Amplified DNA was purified using a Wizard SV gel and PCR clean-up kit according to the manufacturer9s instructions (Promega). The purified DNA was ligated into the positive selection cloning vector pJET (Fermentas) and transformed by heat shock into E. coli DH5a and/or E. coli JM107. Transformants were cultured at 37 uC in Lysogeny Broth (LB) or in LB agar plates containing ampicillin (100 mg ml
21
).
Plasmid DNA for restriction analysis and sequencing was isolated with a small-scale boiling lysis method (Sambrook & Russell, 2001) and restriction enzymes BgIII and XhoI were used to linearize the plasmids in accordance with the manufacturer's instructions (Fermentas). Inserts were sequenced with primers specific for pJET (forward sequencing primer: 59GCCTGAACACCATATCCATCC-39; reverse sequencing primer: 59-GCAGCTGAGAATATTGTAGGAG-ATC-39). When necessary, primers were designed to complete the sequence of the variable region of the cassette arrays by primer walking. DNA sequencing was done with the dideoxy-chaintermination method in a Genetic Analyzer 3130 Autosequencer (Applied Biosystems). Sequence assembly was performed with DNAMan v.6.0 (Lynnon Biosoft). Details of nucleotide sequences deposited in GenBank (http://www.ncbi.nlm.nih.gov) (accession numbers FN824507.1, FN824508.1, FN824509.1 and FN827339.1) are given in Table 1. ERIC2 fingerprinting. Genotyping by ERIC2 (enterobacterial repetitive intergenic consensus) PCR was performed to analyse the clonal relatedness of all 198 P. aeruginosa. These reactions were carried out as previously described (Speijer et al., 1999) . Gel electrophoresis patterns were analysed with the GelCompar II software (Applied Maths) using a cut-off of ¢80 % level of similarity to establish clusters.
RESULTS

Prevalence of resistance to carbapenems and other antibiotics
Out of 198 isolates, 125 (63.1 %) were categorized as carbapenem-resistant using the Vitek system, including 103 isolates showing resistance to both imipenem and meropenem. By contrast, 13 isolates were imipenem-resistant and meropenem-susceptible and nine isolates were imipenem-susceptible and meropenem-resistant. Isolates displaying resistance to imipenem could be divided into three groups: a major group with MICs above 256 mg ml 21 (n579, 68.1 %), a group with MICs of between 16 mg ml 21 and 128 mg ml 21 (n527, 23.7 %), and a minor group comprising isolates with MICs of more than 8 mg ml 21 but less than 16 mg ml 21 (n510, 8.6 %). As shown in Table 2 , the isolates analysed in this study showed a high percentage of resistance to other b-lactams, aminoglycosides and fluoroquinolones. The percentages of resistance were even higher among the carbapenem-resistant isolates, most of which showed resistance to antibiotics of different structural classes. In fact, 111 (88.8 %) of the carbapenem-resistant isolates also showed resistance to ceftazidime, cefepime, aztreonam, ticarcillin/clavulanic acid, amikacin, gentamicin, tobramycin, ciprofloxacin and gatifloxacin. Forty-seven (23.7 %) isolates were resistant to the combination piperacillin/tazobactam.
Detection of metallo-b-lactamase activity and MBL genes
We found 102 MBL producers (81.6 %) among the carbapenem-resistant isolates. None of the carbapenemsusceptible isolates gave positive results in the MBL assays. Strikingly, both bla IMP and bla VIM genes were simultaneously detected in 96 out of the 102 MBL producers (94.1 %). Five carbapenem-resistant MBL producers were positive only for bla IMP genes and another isolate with the same phenotype did not yield amplification products for either bla IMP or bla VIM genes (PAE-029). Both bla IMP and bla VIM genes were also detected in the imipenem-resistant meropenem-resistant isolate PAE-171 (MIC IMP 12 mg ml
21
) and in the imipenem-susceptible meropenemresistant isolate PAE-046 (MIC IMP ,4 mg ml 21 ), both of which showed no MBL activity in the E-test assay. The bla GIM-1 gene was not detected.
Most (n577, 80.2 %) of the isolates carrying both bla IMP and bla VIM genes displayed a MIC to imipenem of ¢256 mg ml
, although the isolates carrying only the bla IMP gene showed a similar phenotype. Carbapenem-resistant isolates lacking both MBL activity and bla IMP and bla VIM genes showed MIC values to imipenem between 6 and 24 mg ml
.
Detection of integrons and sequencing of gene cassettes
Almost 70 % (n5137) of the 198 isolates examined harboured the intI1 gene. This element was accompanied by the sul1 and qacED1 genes in 136 (99 %) and 122 (89 %) isolates, respectively. One hundred and eighteen out of 125 (94.4 %) carbapenem-resistant isolates carry intI1, in contrast to 26.0 % of the carbapenem-susceptible isolates. Ninety-three out of 96 (96.8 %) isolates carrying both bla IMP and bla VIM genes also harboured the intI1, sul1 and qacED1 genes. Three bla IMP + bla VIM + isolates also carried the intI1 and sul1 but lacked qacED1.
Analysis of gene cassettes amplified from 19 intI1
+ carbapenem-susceptible and MBL-negative carbapenemresistant isolates generated single products ranging in size The most prevalent gene cassette was aacA4, followed closely by aadA6 and orfD (Table 1) . In contrast, amplification analysis of gene cassettes using the primers 59CS and 39CS of intI1 + bla IMP + bla VIM + isolates revealed a predominant 180 bp product, which probably represented empty integron(s), and several discrete faint bands of higher molecular mass, which may indicate the presence of multiple gene cassettes (data not shown). In an attempt to determine the gene cassette sequences of bla IMP and bla VIM , and the structure of the corresponding integrons, we attempted several times to clone these multiple amplifications products in pJET and to select for E. coli DH5a and E. coli JM107 colonies with imipenem-resistance. These efforts were unsuccessful.
Allelic variants of bla IMP and bla VIM
Cloning and sequence analysis of MBL amplification products (Mendes et al., 2007) obtained from one representative carbapenem-resistant isolate, P. aeruginosa PAE-006, indicated that bla IMP corresponds to bla IMP-18 and bla VIM to bla VIM-2 . The open reading frame sequence of bla IMP-18 is 100 % identical to those present in In706 and In707, two class 1 integrons recently described in Puerto Rico (GenBank No. JN596991.2, Martinez et al., 2012) . The sequence of the bla VIM-2 gene showed 100 % identity to those of the gene cassettes present in In56, In58, In59 and In72, which were the first descriptions of the nucleotide sequence of this bla VIM variant (Pallecchi et 
Diversity of P. aeruginosa isolates assessed by ERIC2 analysis
One hundred and eighty isolates yielded appropriate ERIC2 patterns to be analysed using the GelCompar II software (Table S1 , available in the online Supplementary Material). Of these, 126 isolates were classified in 29 clusters, each of which included 2-12 isolates. These data reflect a high level of diversity in the P. aeruginosa isolates analysed. The 126 isolates included 90 bla IMP + bla VIM + isolates, five bla IMP + bla VIM 2 isolates and 85 bla IMP 2 bla VIM 2 isolates. Eighty of the 90 bla IMP + bla VIM + isolates were sorted in 16 different clusters, and 10 of these isolates showed a level of similarity below 80 %, suggesting that the bla IMP and bla VIM genes detected are probably linked in a genetic structure susceptible to lateral transfer.
Association of carbapenem resistance to hospital epidemiology
There was no statistically significant difference between the recovery of carbapenem-resistant MBL-positive and carpabenem-susceptible isolates and the sex of the patients or the type of specimen, with the exception of the specimens in the category 'other' (79.3 % versus 20.7 % P50.061). Carbapenem-resistant MBL-positive isolates were recovered from almost all hospital wards and were overrepresented in samples obtained from the surgical emergency (92.3 %) and intensive care therapy (91.3 %) units. Remarkably, seven carbapenem-resistant isolates were recovered from outpatients, of which three displayed MBL activity and carried both bla IMP and bla VIM genes.
DISCUSSION
Resistance to carbapenems is a predominant feature among P. aeruginosa isolates recovered from a major tertiary-level health facility in San José, Costa Rica. This finding is quite alarming because the vast majority of these isolates also showed resistance to other b-lactams, aminoglycosides and fluoroquinolones. The percentage of the P. aeruginosa isolates exhibiting resistance to carbapenems observed in this study (63.1 %) is much higher than the frequencies observed in previous studies (reviewed in Andrade et al., 2003; Lister et al., 2009) . The low number of therapeutic alternatives available to treat infections caused by this pathogen, particularly those occurring in immunocompromised patients with underlying conditions, poses a serious threat to public health. Patients infected with MBLproducing P. aeruginosa are treated in this hospital with high doses of carbapenems (either imipenem or meropenem), along with an aminoglycoside or piperacillintazobactam or with colistin/polymixin B and rifampicin (A. A. Avilés-Montoya, personal communication).
Since production of metallo-b-lactamases is a major mechanism of resistance to carbapenems, detection of MBL activity in most of the carbapenem-resistant isolates was not unexpected. However, resistance to carbapenems could not be explained by the production of MBLs in 23 isolates, indicating that other mechanisms should be involved. Interestingly, in most of the strains, resistance to carbapenems could be explained by the presence of not just one, but two metallo-b-lactamases encoded by bla IMP and bla VIM genes, while the bla GIM-1 gene was not detected. Expression analyses of bla IMP and bla VIM should be performed to precisely define the contribution of each gene to the resistance to carbapenems in selected isolates from our collection. Additional mechanisms, including other serine-and metallo-b-lactamases, porins and efflux pumps were not analysed and their contribution to the phenotype of resistance to carbapenems in our P. aeruginosa isolates cannot be disregarded.
More than 30 allelic variants in diverse bacterial species have been reported for both bla IMP and bla VIM , the most frequent MBL genes in P. aeruginosa isolates (Cornaglia et al., 2011; Walsh et al., 2005; Nicolau & Oliver, 2010) . Sequence analysis of the MBL genes from one isolate (PAE-006) indicated that the bla IMP corresponds to bla IMP-18 and the bla VIM to bla VIM-2 . Since allelic variants of the corresponding bla IMP and bla VIM genes were not determined in other P. aeruginosa isolates from the same hospital, we cannot assume that both alleles are predominant among the isolates carrying both genes. However, we analysed carbapenem-resistant P. aeruginosa isolated in other hospitals in San José, specifically, P. aeruginosa AG1 (GenBank No. KC907377.1, KC907378.1) from the Hospital San Juan de Dios (general hospital, 720 beds) and P. aeruginosa GRI from the Hospital Nacional de Niños (paediatric hospital, 330 beds). Strikingly, both isolates also carry bla IMP-18 and bla VIM-2 genes showing 100 % sequence identity to the sequences obtained from P. aeruginosa unpublished) . These data provide evidence for interhospital dissemination of P. aeruginosa carrying both bla IMP-18 and bla VIM-2 .
Whereas the bla VIM-2 gene has been reported in outbreaks in more than 29 countries or regions around the world in over 50 different integron structures and is considered the most important VIM-type MBL in clinical settings (Zhao & Hu, 2011a, b) , the distribution of the bla IMP-18 gene is more limited. The bla IMP-18 gene was first described in a P. aeruginosa isolate in the United States in 2006 (Borgianni et al. 2011; Hanson et al., 2006) , and has since been identified in Mexico and France (Garza-Ramos et al., 2008; Hocquet et al., 2010; Wolter et al., 2009) . More recently, bla IMP-18 has been associated with two class 1 integrons, In706 and In707, in P. aeruginosa isolates recovered in Puerto Rico (Martinez et al., 2012) .
To our knowledge, this is the first report of the combination of two metallo-b-lactamases encoded by the bla IMP-18 and bla VIM-2 genes in P. aeruginosa. Recently, P. aeruginosa isolates carrying both bla VIM-2 and bla VIM-11 have been described in Mexico (Castillo-Vera et al., 2012) .
Other combinations of MBL genes have also been described in Serratia marcescens (bla IMP-8 and bla VIM-11 encoded by a class 1 integron) (Lee et al., 2008) , Klebsiella pneumoniae (bla IMP and bla SIM-1 , bla VIM and bla SIM-1 ), Enterobacter aerogenes (bla IMP and bla SIM-1 ) (Dwivedi et al., 2009) and Acinetobacter genospecies 10 isolates (bla IMP-1 and bla VIM-2 , bla IMP-1 and bla SIM-1 , bla VIM-2 and bla SIM-1 , separately encoded each by class 1 integrons) (Lee et al., 2010) .
Most of the P. aeruginosa isolates examined harboured the intI1 gene accompanied by the sul1 and qacED1 genes. Occurrence of class 1 integron-like structures was more predominant among carbapenem-resistant isolates, particularly in those carrying both bla IMP and bla VIM , than among carbapenem-susceptible isolates. However, although bla IMP and bla VIM genes have been separately associated with class 1 integrons in other studies, we cannot directly demonstrate this physical association in our isolates. Carbapenemresistant isolates carrying both bla IMP and bla VIM genes generated multiple faint bands of diverse sizes in our PCR approach for the amplification of the gene cassettes, strongly suggesting the occurrence of multiple integrons in those isolates. Carbapenem-susceptible and MBL-negative carbapenem-resistant isolates instead yielded single amplification products of gene cassettes encoding mostly for aminoglycoside-resistance enzymes. Thus, MBL-producing P. aeruginosa isolates carrying both bla IMP and bla VIM genes seem to differ from carbapenem-susceptible and MBL-negative carbapenem-resistant isolates with regard to the structure of their integrons. Preliminary data derived from a current genomic study in our lab using a genomic approach indicate that the bla IMP-18 and bla VIM-2 genes of P. aeruginosa AG1 are separately associated with different class 1 integron-like structures, each of which being, in turn, a part of distinct transposons (A. Guzmán-Marte and others, unpublished). It has been recently reported that class 1 integrons/transposons seem to be undergoing successful dispersal by lateral gene transfer in P. aeruginosa clinical isolates (Martinez et al., 2012) . This fact could explain the occurrence of both bla IMP and bla VIM genes among isolates belonging to diverse ERIC2 clusters or lineages of P. aeruginosa.
In order to determine if the bla genes are localized in plasmids, several assays were performed in selected MBLpositive P. aeruginosa isolates, including plasmid purification by diverse protocols and gel electrophoresis analysis, curing experiments under several conditions, as well as conjugation experiments with or without a helper plasmid (pUB307) using various carbapenem-sensitive E. coli and P. aeruginosa strains as receptors cells (data not shown). All results were negative suggesting that bla IMP and bla VIM are probably located on the chromosome of the carbapenemresistant P. aeruginosa isolates. Since carbapenem-resistent P. aeruginosa isolates carry several lysogenic phages on the chromosome (C. Rodríguez and F. García, unpublished results), we are currently testing the hypothesis that horizontal transfer of bla IMP and bla VIM might occur by transduction.
Carbapenem-resistant MBL-positive P. aeruginosa isolates carrying both bla IMP and bla VIM genes were recovered from almost all hospital services, particularly from the intensive care therapy and surgical emergency units, as well as from outpatients, and from two other major hospitals in San José. These data suggest that community-acquired infections as well as inter-hospital dissemination of bla IMP + bla VIM + P. aeruginosa, probably by the transfer of colonized or infected patients between hospitals, have been occurring.
In conclusion, we describe the predominance of carbapenem-resistant MBL-producing P. aeruginosa in a hospital setting in San José, Costa Rica. Our isolates exhibited high percentages of resistance to other b-lactams, fluoroquinolones and aminoglycosides, and were also recovered from outpatients as well as from other hospitals, suggesting community-acquired infections as well as inter-hospital dissemination. We provide evidence that the majority of those isolates carry both bla IMP and bla VIM genes, probably linked in an integron-like structure susceptible to lateral transfer. Finally, we report the simultaneous presence of the allelic variants bla IMP-18 and bla VIM-2 encoding metallob-lactamases in P. aeruginosa.
